Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease
- 1 September 1995
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (9) , 1314-1320
- https://doi.org/10.1161/01.atv.15.9.1314
Abstract
Abstract To examine the graded risks for coronary artery disease (CAD) associated with plasma homocyst(e)ine [H(e)] and to evaluate the extent to which this risk is mediated by altered vitamin status, we measured plasma concentrations of H(e), vitamins B 6 and B 12 , and folate as well as other coronary risk factors in subjects with early familial CAD and in control subjects. We studied 120 male and 42 female patients with early CAD who were unrelated to each other but were from families in which at least one other sibling had early CAD. Control subjects were 85 men and 70 women with the same age range (38 to 68) as the subjects with CAD at screening. Increasing H(e) was associated with graded increased risks of CAD that appeared consistent with a multiplicative model. Relative odds for CAD were approximately 12.8 in women when those with H(e) levels of 19 μmol/L and above were compared with those with H(e) levels of 9 μmol/L or less ( P =.007). For men, the same comparison yielded relative odds of 13.8 ( P =.0002). Plasma H(e) remained a strong, independent risk factor after adjustment for standard risk factors and plasma vitamin levels in multiple logistic regression (relative odds, 8.1 for a 10-μmol/L increase in H(e); 95% confidence interval, 3.2 to 20.4; P <.0001). In multivariate ANCOVA the slope of H(e) versus folate was much steeper in subjects with CAD than in control subjects ( P =.0035). These data suggest that high plasma H(e) is an important, independent contributor to risk for early familial CAD. Furthermore, subjects with early familial CAD who had low plasma folate levels had exaggerated elevations in plasma H(e), suggesting a possible genetic sensitivity to the detrimental effects of lower folate intake.Keywords
This publication has 28 references indexed in Scilit:
- Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folateThe American Journal of Cardiology, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Screening for mutations by expressing patient cDNA segments inE. coli: Homocystinuria due to cystathionine β-synthase deficiencyHuman Mutation, 1992
- Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.Journal of Clinical Investigation, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Homocyst(e)inemia in daily practiceCoronary Artery Disease, 1990
- Homocysteine and myocardial infarctionAtherosclerosis, 1988
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985